News

Statins May Reduce VTE Risk Associated with Hormone Therapy

Hormone therapy (HT) is associated with an increased risk of venous thromboembolism (VTE), but can statins (often used concurrently with HT in postmenopausal women) reduce this occurrence?

Persistent Pain in Older Patients: Best Practices

Persistent pain in later life is prevalent, costly, and often disabling to patients.

Atypical Antipsychotics - Safe for Elderly Patients?

The use of conventional antipsychotics among the elderly has been limited due to severe side effects, but atypical antipsychotics have become widely prescribed but with increasing concerns over safety risks such as stroke and mortality in elderly patients with dementia.

Potential Treatment for BAM-Associated Diarrhea in Crohn's Disease?

A bile acid sequestrant currently indicated for the treatment of type 2 diabetes and primary hyperlipidemia could also help Crohn's disease (CD) patients with bile acid malabsorption (BAM)-associated diarrhea.

Weighty and Wealthy: The Money-Obesity Association

Does wealth influence your weight? Researchers sought to find out how money correlates to body mass index (BMI) in men and women.

Health Care Protective Gear Lacking in Ebola Outbreak

Health care workers in poor nations often do not have enough protective gear to keep them safe from being infected with blood-borne viruses such as Ebola and HIV.

Pay-for-Performance Not Found to Impact Access to CABG

For patients with acute myocardial infarction (AMI), treatment at pay-for-performance (P4P) hospitals is not associated with a change in the rate of coronary artery bypass graft (CABG) surgery.

Diabetes Risk Increased for Hodgkin's Lymphoma Survivors

Para-aortic radiation correlates with increased diabetes mellitus (DM) risk for Hodgkin's lymphoma (HL) survivors.

Stiff Person Syndrome: Remission with Stem Cells

For patients with stiff person syndrome (SPS), autologous hematopoietic stem cell transplantation (auto-HSCT) can induce prolonged clinical remission.

Are MI Trial Results Generalizable to Typical Patients?

Low levels of enrollment and more favorable risk profiles for participants raise questions about whether the findings of clinical trials are generalizable to typical patients with myocardial infarction (MI).